1. Home
  2. GLUE vs MMS Comparison

GLUE vs MMS Comparison

Compare GLUE & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLUE
  • MMS
  • Stock Information
  • Founded
  • GLUE 2019
  • MMS 1975
  • Country
  • GLUE United States
  • MMS United States
  • Employees
  • GLUE N/A
  • MMS N/A
  • Industry
  • GLUE Biotechnology: Pharmaceutical Preparations
  • MMS Business Services
  • Sector
  • GLUE Health Care
  • MMS Consumer Discretionary
  • Exchange
  • GLUE Nasdaq
  • MMS Nasdaq
  • Market Cap
  • GLUE N/A
  • MMS 3.9B
  • IPO Year
  • GLUE 2021
  • MMS 1997
  • Fundamental
  • Price
  • GLUE $4.14
  • MMS $75.95
  • Analyst Decision
  • GLUE Buy
  • MMS Buy
  • Analyst Count
  • GLUE 3
  • MMS 1
  • Target Price
  • GLUE $14.33
  • MMS $90.00
  • AVG Volume (30 Days)
  • GLUE 573.6K
  • MMS 438.4K
  • Earning Date
  • GLUE 05-08-2025
  • MMS 05-08-2025
  • Dividend Yield
  • GLUE N/A
  • MMS 1.58%
  • EPS Growth
  • GLUE N/A
  • MMS 31.21
  • EPS
  • GLUE 0.08
  • MMS 5.00
  • Revenue
  • GLUE $159,487,000.00
  • MMS $5,395,260,000.00
  • Revenue This Year
  • GLUE N/A
  • MMS $0.90
  • Revenue Next Year
  • GLUE N/A
  • MMS $3.08
  • P/E Ratio
  • GLUE $54.46
  • MMS $15.16
  • Revenue Growth
  • GLUE 14889.38
  • MMS 5.29
  • 52 Week Low
  • GLUE $3.21
  • MMS $63.77
  • 52 Week High
  • GLUE $12.40
  • MMS $93.97
  • Technical
  • Relative Strength Index (RSI)
  • GLUE 45.31
  • MMS 66.61
  • Support Level
  • GLUE $3.76
  • MMS $65.67
  • Resistance Level
  • GLUE $4.62
  • MMS $76.38
  • Average True Range (ATR)
  • GLUE 0.35
  • MMS 1.80
  • MACD
  • GLUE -0.03
  • MMS 0.74
  • Stochastic Oscillator
  • GLUE 40.35
  • MMS 77.85

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: